Astera Labs, Inc. $ALAB Stock Bought by Park Avenue Securities LLC

Park Avenue Securities LLC boosted its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 7.8% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 58,995 shares of the company’s stock after purchasing an additional 4,281 shares during the quarter. Park Avenue Securities LLC’s holdings in Astera Labs were worth $21,000,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Greenleaf Trust raised its position in shares of Astera Labs by 1.8% during the second quarter. Greenleaf Trust now owns 2,000 shares of the company’s stock valued at $966,000 after buying an additional 36 shares during the last quarter. Parkside Financial Bank & Trust boosted its position in shares of Astera Labs by 74.5% during the second quarter. Parkside Financial Bank & Trust now owns 96 shares of the company’s stock worth $46,000 after acquiring an additional 41 shares during the last quarter. Integrated Advisors Network LLC boosted its position in shares of Astera Labs by 4.8% during the third quarter. Integrated Advisors Network LLC now owns 983 shares of the company’s stock worth $350,000 after acquiring an additional 45 shares during the last quarter. Glenmede Trust Co. NA boosted its position in shares of Astera Labs by 2.7% during the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock worth $209,000 after acquiring an additional 51 shares during the last quarter. Finally, Keating Financial Advisory Services Inc. purchased a new position in Astera Labs during the second quarter valued at $25,000. 60.47% of the stock is currently owned by institutional investors.

Insider Activity

In related news, CEO Jitendra Mohan sold 90,630 shares of the firm’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief executive officer directly owned 1,266,665 shares in the company, valued at $431,109,432.75. This trade represents a 6.68% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, General Counsel Philip Mazzara sold 6,801 shares of Astera Labs stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the transaction, the general counsel directly owned 96,542 shares of the company’s stock, valued at $32,872,551. The trade was a 6.58% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders have sold 408,558 shares of company stock worth $127,306,034. Company insiders own 10.40% of the company’s stock.

Astera Labs Stock Performance

Shares of ALAB opened at $259.51 on Tuesday. The stock has a market capitalization of $45.02 billion, a PE ratio of 128.47 and a beta of 3.68. The company’s fifty day moving average is $310.76 and its 200 day moving average is $252.11. Astera Labs, Inc. has a fifty-two week low of $97.89 and a fifty-two week high of $499.48.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. During the same period in the previous year, the firm posted $0.44 EPS. The business’s quarterly revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, research analysts forecast that Astera Labs, Inc. will post 2.71 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on ALAB. Citigroup downgraded shares of Astera Labs from a “buy” rating to a “hold” rating in a report on Friday, October 9th. Weiss Ratings downgraded shares of Astera Labs from a “buy (b-)” rating to a “hold (c)” rating in a report on Friday. Royal Bank Of Canada raised their price objective on Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a research report on Wednesday, August 5th. Susquehanna lifted their target price on Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a report on Friday, July 31st. Finally, Zacks Research downgraded Astera Labs from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 5th. Eleven analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $340.79.

Astera Labs Profile

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.